Nexentis Technologies Inc.

NXTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Sep 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Jun 2023 Mar 2023
Revenue $2.0K $66.0K $140.2K $9.0K $17.0K $43.8K $36.6K $121.0K
Cost of Revenue $2.0K $14.0K $54.0K $77.0K $6.0K $28.0K $27.0K $42.7K
Gross Profit $0 $52.0K $86.0K $-68.0K $11.0K $16.0K $9.6K $78.3K
Gross Margin 0.0% 78.8% 61.4% -755.6% 64.7% 36.5% 26.2% 64.7%
Operating Expenses
Research & Development $52.0K $20.0K $228.0K $19.0K $6.0K $116.0K $16.9K $118.9K
SG&A Expense $1.2M $503.0K $462.0K $1.3M $795.0K $742.0K $744.3K $1.6M
Operating Income $-1.3M $-503.0K $-101.0K $-1.4M $-847.0K $-899.0K $-840.3K $-1.7M
Operating Margin -66,300.0% -762.1% -72.1% -15,955.6% -4,982.4% -2,051.1% -2,295.4% -1,440.9%
Interest Expense — — — — — — — —
Pretax Income — $-1.1M — — — — — —
Income Tax Expense — — — — — — — —
Net Income $429.0K $-1.2M $-1.4M $-2.3M $-787.0K $-769.0K $-709.5K $-1.7M
Net Margin 21,450.0% -1,807.6% -979.5% -25,155.6% -4,629.4% -1,754.5% -1,938.1% -1,416.1%
EPS (Basic) $0.06 $-2.57 $-1.85 $-2.04 $-0.03 $-0.04 $-0.05 $-0.18
EPS (Diluted) $0.14 $-12.18 $-3.84 $-0.06 $-0.03 $-0.04 $-0.05 $-0.18
Shares Outstanding (Basic) 6.6M 113.2M 1.3M 1.2M 23.9M 20.7M 14.4M 9.7M
Shares Outstanding (Diluted) 6.8M 156.0M 1.3M 40.7M 23.9M 20.7M 14.4M 9.7M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →